It plans to use Cambridge-1 to design antibodies that would assist deal with a quantity of inflammatory issues. Oxford Nanopore is further accelerating its research with Cambridge-1, enabling its algorithms group to realize identical day outcomes that accelerate research with more highly effective and impactful genomics functions. With the computational resources of Cambridge-1, GSK is…